These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7950475)

  • 1. Statistical methods for clinical trials.
    Bailey A; Crook A; Machin D
    Blood Rev; 1994 Jun; 8(2):105-12. PubMed ID: 7950475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and analysis of prostate cancer trials.
    Sylvester R
    Acta Urol Belg; 1994 Apr; 62(1):23-9. PubMed ID: 8197926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical principles for clinical trials.
    Kay R
    J Int Med Res; 1998; 26(2):57-65. PubMed ID: 9602983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A primer on the design, conduct, and interpretation of clinical trials.
    Appel LJ
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1360-7. PubMed ID: 17699370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity versus generalizability in clinical trial design and conduct.
    Hennekens CH; Buring JE
    J Card Fail; 1998 Sep; 4(3):239-41. PubMed ID: 9754597
    [No Abstract]   [Full Text] [Related]  

  • 6. Good intentions and ICH-GCP: Trial conduct training needs to go beyond the ICH-GCP document and include the intention-to-treat principle.
    Browne LH; Graham PH
    Clin Trials; 2014 Dec; 11(6):629-34. PubMed ID: 25023199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study design: statistical and methodologic considerations.
    Rubenfeld GD
    Respir Care; 1995 Sep; 40(9):980-6. PubMed ID: 10152244
    [No Abstract]   [Full Text] [Related]  

  • 8. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e305-7. PubMed ID: 15173053
    [No Abstract]   [Full Text] [Related]  

  • 9. Q&A: Rajeshwari Sridhara, Robert Temple on trial design. Interviewed by Suzanne Rose.
    Sridhara R; Temple R
    Cancer Discov; 2013 Mar; 3(3):245. PubMed ID: 23475863
    [No Abstract]   [Full Text] [Related]  

  • 10. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials.
    Kunz R; Oxman AD
    BMJ; 1998 Oct; 317(7167):1185-90. PubMed ID: 9794851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raw data from clinical trials: within reach?
    Doshi P; Goodman SN; Ioannidis JP
    Trends Pharmacol Sci; 2013 Dec; 34(12):645-7. PubMed ID: 24295825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of preservation of the ethical principle of equipoise in the design of clinical trials: relative impact of the methodological quality domains on the treatment effect in randomized controlled trials.
    Djulbegovic B; Cantor A; Clarke M
    Account Res; 2003; 10(4):301-15. PubMed ID: 14989285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical Controversies in Reporting of Clinical Trials: Part 2 of a 4-Part Series on Statistics for Clinical Trials.
    Pocock SJ; McMurray JJV; Collier TJ
    J Am Coll Cardiol; 2015 Dec; 66(23):2648-2662. PubMed ID: 26670066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General design issues in efficacy, equivalency and superiority trials.
    Fleiss JL
    J Periodontal Res; 1992 Jul; 27(4 Pt 2):306-13; discussion 323-7. PubMed ID: 1507018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis.
    White B; Bauer EA; Goldsmith LA; Hochberg MC; Katz LM; Korn JH; Lachenbruch PA; LeRoy EC; Mitrane MP; Paulus HE
    Arthritis Rheum; 1995 Mar; 38(3):351-60. PubMed ID: 7880189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothesis testing in clinical trials.
    Green SB
    Hematol Oncol Clin North Am; 2000 Aug; 14(4):785-95, vii-viii. PubMed ID: 10949773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Basic principles of clinical trials--what, how, and why?].
    Unnebrink K; Pritsch M
    Med Klin (Munich); 1999 Aug; 94(8):458-64. PubMed ID: 10495627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designs for efficient clinical trials.
    Simon R
    Oncology (Williston Park); 1989 Jul; 3(7):43-9; discussion 51-3. PubMed ID: 2701811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can non-randomized trials be considered to be equivalent to randomized trials in forensic mental health?
    Leese M
    Crim Behav Ment Health; 2005; 15(2):121-2. PubMed ID: 16470506
    [No Abstract]   [Full Text] [Related]  

  • 20. Bias control in clinical trials: masking or blinding.
    Galvez-Olortegui JK; Gonzales-Saldaña J; Garcia-Gomez I; Silva-Ocas I; Gutierrez-Arana J; Galvez-Olortegui T; Condor-Rojas YC
    Medwave; 2015 Dec; 15(11):e6349. PubMed ID: 26731671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.